A Blind, Randomized and Controlled Clinical Trial to Evaluate the Protective Effect, Safety and Immunogenicity of Live Attenuated Varicella Vaccines for Healthy Children
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 08 Dec 2016
At a glance
- Drugs Varicella zoster vaccine Sinovac Biotech (Primary)
- Indications Varicella zoster virus infections
- Focus Therapeutic Use
- Sponsors Sinovac (Dalian) Vaccine Technology
- 28 Nov 2016 According to a Sinovac Biotech media release, the company expects to complete this trial in the third quarter of 2017.
- 19 Oct 2016 According to a Sinovac Biotech media release, status changed from planning to recruiting.
- 23 Sep 2016 According to a Sinovac Biotech media release, this trial is expected to initiate in September 2016.